Evidence map›Paper›PMID 42027492›Full record

ArticleAnnals of thoracic surgery short reports2026

Local Consolidative Surgery for Oligometastatic Non-Small Cell Lung Cancer With Bone Metastasis.

Zamaan Hooda, Shanique Ries, Michael Eisenberg, Raphael Werner, Wayne Hofstetter, Reza Mehran, Ravi Rajaram, David Rice, Stephen Swisher, Ara Vaporciyan and 4 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Annals of thoracic surgery short reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Zamaan HoodaDepartment of Thoracic and Cardiovascular Surgery, University of Texas MD Anderson Cancer Center, Houston, Texas.
Shanique RiesDepartment of Thoracic and Cardiovascular Surgery, University of Texas MD Anderson Cancer Center, Houston, Texas.
Michael EisenbergDepartment of Thoracic and Cardiovascular Surgery, University of Texas MD Anderson Cancer Center, Houston, Texas.
Raphael WernerDepartment of Thoracic Surgery, University Hospital Zurich, Zurich, Switzerland.
Wayne HofstetterDepartment of Thoracic and Cardiovascular Surgery, University of Texas MD Anderson Cancer Center, Houston, Texas.
Reza MehranDepartment of Thoracic and Cardiovascular Surgery, University of Texas MD Anderson Cancer Center, Houston, Texas.
Ravi RajaramDepartment of Thoracic and Cardiovascular Surgery, University of Texas MD Anderson Cancer Center, Houston, Texas.
David RiceDepartment of Thoracic and Cardiovascular Surgery, University of Texas MD Anderson Cancer Center, Houston, Texas.
Stephen SwisherDepartment of Thoracic and Cardiovascular Surgery, University of Texas MD Anderson Cancer Center, Houston, Texas.
Ara VaporciyanDepartment of Thoracic and Cardiovascular Surgery, University of Texas MD Anderson Cancer Center, Houston, Texas.
Garrett WalshDepartment of Thoracic and Cardiovascular Surgery, University of Texas MD Anderson Cancer Center, Houston, Texas.
Isabelle OpitzDepartment of Thoracic Surgery, University Hospital Zurich, Zurich, Switzerland.
Kyle G MitchellDepartment of Thoracic and Cardiovascular Surgery, University of Texas MD Anderson Cancer Center, Houston, Texas.
Mara B AntonoffDepartment of Thoracic and Cardiovascular Surgery, University of Texas MD Anderson Cancer Center, Houston, Texas.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Local consolidative therapy (LCT) can improve overall survival (OS) and progression-free survival (PFS) in oligometastatic non-small cell lung cancer (NSCLC). Bone metastases (BM) are associated with poorer prognosis after LCT. However, the prognostic influence of BM on outcomes after pulmonary resection remains unknown, particularly in an era with advanced systemic therapies. Methods: We identified patients from 2 centers with oligometastatic (≤3 synchronous sites) NSCLC who underwent pulmonary resection from 1996 to 2023. Patients were stratified by BM presence. Survival outcomes were evaluated by Kaplan-Meier and multivariable Cox regression models. Results: There were 87 patients who met study criteria, including 10 (11.5%) patients with BM (+BM) and 77 (88.5%) without (-BM). Age and smoking patterns were not statistically different between groups, and median number of metastatic sites was 1.0 (interquartile range, 0) for all. Notably, median OS was similar between groups, 39.2 months for +BM (95% CI, 11.81-66.51) and 37.5 months for -BM (95% CI, 22.92-51.98; Conclusions: In this contemporary study of patients with oligometastatic NSCLC undergoing pulmonary resection as part of comprehensive LCT, +BM patients were not observed to have poorer survival outcomes. Multidisciplinary teams should consider aggressive LCT approaches including pulmonary resection in this setting.

Identifiers

PMID42027492
PMCPMC13100787

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.